Low serum tryptophan to large neutral amino acids ratio in idiopathic infantile autism. 1995

P D'Eufemia, and R Finocchiaro, and M Celli, and L Viozzi, and D Monteleone, and O Giardini
Department of Pediatrics, University La Sapienza, Rome, Italy.

The serum tryptophan to large neutral amino acids ratio (Try/LNAA) is considered a reliable marker of tryptophan availability for brain serotonin synthesis. A dysfunction of brain serotonergic activity has been postulated to exist in autistic disorder and supported by recent studies. On this basis, we determined the serum amino acids levels in 40 children with idiopathic infantile autism as well as in 46 control children. A significantly lower serum Try/LNAA ratio was observed in the autistic subjects compared to the normal controls. In 14 autistic children (35%) this ratio was 2 SD below the mean value obtained in the control group. These results suggest that a low brain tryptophan availability due to a low serum Try/LNAA ratio could be one of the possible mechanisms involved in the alteration of serotonergic function in autism.

UI MeSH Term Description Entries
D008297 Male Males
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D001321 Autistic Disorder A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V) Autism, Infantile,Kanner's Syndrome,Autism,Autism, Early Infantile,Disorder, Autistic,Disorders, Autistic,Early Infantile Autism,Infantile Autism,Infantile Autism, Early,Kanner Syndrome,Kanners Syndrome
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine
D014364 Tryptophan An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals. Ardeydorm,Ardeytropin,L-Tryptophan,L-Tryptophan-ratiopharm,Levotryptophan,Lyphan,Naturruhe,Optimax,PMS-Tryptophan,Trofan,Tryptacin,Tryptan,Tryptophan Metabolism Alterations,ratio-Tryptophan,L Tryptophan,L Tryptophan ratiopharm,PMS Tryptophan,ratio Tryptophan

Related Publications

P D'Eufemia, and R Finocchiaro, and M Celli, and L Viozzi, and D Monteleone, and O Giardini
January 1996, Journal of affective disorders,
P D'Eufemia, and R Finocchiaro, and M Celli, and L Viozzi, and D Monteleone, and O Giardini
January 1996, Advances in experimental medicine and biology,
P D'Eufemia, and R Finocchiaro, and M Celli, and L Viozzi, and D Monteleone, and O Giardini
January 1994, Neuropsychobiology,
P D'Eufemia, and R Finocchiaro, and M Celli, and L Viozzi, and D Monteleone, and O Giardini
December 1976, The Biochemical journal,
P D'Eufemia, and R Finocchiaro, and M Celli, and L Viozzi, and D Monteleone, and O Giardini
March 2023, Scientific reports,
P D'Eufemia, and R Finocchiaro, and M Celli, and L Viozzi, and D Monteleone, and O Giardini
March 1994, Biological psychiatry,
P D'Eufemia, and R Finocchiaro, and M Celli, and L Viozzi, and D Monteleone, and O Giardini
January 1983, Journal of neural transmission,
P D'Eufemia, and R Finocchiaro, and M Celli, and L Viozzi, and D Monteleone, and O Giardini
November 1988, Diabetes research (Edinburgh, Scotland),
P D'Eufemia, and R Finocchiaro, and M Celli, and L Viozzi, and D Monteleone, and O Giardini
May 1994, Nihon rinsho. Japanese journal of clinical medicine,
P D'Eufemia, and R Finocchiaro, and M Celli, and L Viozzi, and D Monteleone, and O Giardini
January 1999, Advances in experimental medicine and biology,
Copied contents to your clipboard!